TYPHIBEV, a second TCV, was prequalified by WHO in 2020. Nepal, Malawi, and Burkina Faso introduced TYPHIBEV into their routine immunization programs in 2022, 2023, and 2025, respectively.
TYPHIBEV, a second TCV, was prequalified by WHO in 2020. Nepal, Malawi, and Burkina Faso introduced TYPHIBEV into their routine immunization programs in 2022, 2023, and 2025, respectively.

